Conference Coverage

Novel Long-Acting Insulin Causes Less Hypoglycemia


 

FROM THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS

All of the reported studies were funded by Novo Nordisk.

Pages

Recommended Reading

Less Vascular Care Tied to More Amputations
MDedge Endocrinology
Early, Aggressive Glucose Control in Prediabetes Key
MDedge Endocrinology
Gastric Bypass Induces Diabetes Remission in Mildly Obese
MDedge Endocrinology
Systematic QI Strategies Lift all Boats in Diabetes Care
MDedge Endocrinology
Exenatide Bests Glimepiride as a Metformin Add-On
MDedge Endocrinology
Rapid HbA1c Rise in a Child? Intensify Treatment Fast
MDedge Endocrinology
Aggressive BP Lowering in Diabetes No Boost to CVD Outcomes
MDedge Endocrinology
SEARCH Turns Up More Diabetes in Youth
MDedge Endocrinology
Three Glargine Studies Find No Link to Cancer
MDedge Endocrinology
Add-On Glargine Bests Sitagliptin for Regaining Glucose Control
MDedge Endocrinology